Stockscreener 앱 받기
28.19
1.74%
-0.50
시장 영업 전:
28.55
0.36
+1.28%
전일 마감가:
$28.69
열려 있는:
$28.86
하루 거래량:
1.42M
Relative Volume:
0.60
시가총액:
$4.65B
수익:
$1.51B
순이익/손실:
$333.35M
주가수익비율:
14.46
EPS:
1.95
순현금흐름:
$315.22M
1주 성능:
-9.09%
1개월 성능:
-9.01%
6개월 성능:
-10.99%
1년 성능:
+1.00%
1일 변동 폭
$28.12
$29.24
1주일 범위
$28.12
$30.36
52주 변동 폭
$25.16
$36.45
Alkermes Plc Stock (ALKS) Company Profile
명칭
Alkermes Plc
전화
00-353-1-772-8000
주소
CONNAUGHT HOUSE, DUBLIN 4
ALKS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALKS
Alkermes Plc
|
28.19 | 4.74B | 1.51B | 333.35M | 315.22M | 1.95 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Alkermes Plc Stock (ALKS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-11 | 개시 | Truist | Buy |
| 2025-09-26 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-09-03 | 개시 | Wells Fargo | Overweight |
| 2025-07-15 | 개시 | Goldman | Buy |
| 2025-06-17 | 업그레이드 | UBS | Neutral → Buy |
| 2025-05-28 | 개시 | Needham | Buy |
| 2025-03-13 | 개시 | RBC Capital Mkts | Sector Perform |
| 2025-03-04 | 업그레이드 | UBS | Sell → Neutral |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-11-05 | 업그레이드 | Stifel | Hold → Buy |
| 2024-06-17 | 개시 | TD Cowen | Buy |
| 2024-03-19 | 개시 | Robert W. Baird | Outperform |
| 2024-02-20 | 다운그레이드 | UBS | Neutral → Sell |
| 2023-11-20 | 재개 | JP Morgan | Neutral |
| 2023-10-24 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-10-17 | 개시 | UBS | Neutral |
| 2022-11-03 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-10-14 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-08-16 | 개시 | Piper Sandler | Neutral |
| 2022-04-22 | 재개 | Goldman | Buy |
| 2022-04-20 | 개시 | Goldman | Buy |
| 2022-01-27 | 업그레이드 | Cantor Fitzgerald | Hold → Overweight |
| 2021-12-01 | 개시 | Citigroup | Neutral |
| 2021-10-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-09-02 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2020-10-15 | 업그레이드 | Mizuho | Neutral → Buy |
| 2020-07-30 | 다운그레이드 | Goldman | Neutral → Sell |
| 2020-02-14 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2020-02-14 | 재확인 | H.C. Wainwright | Neutral |
| 2020-02-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-02-06 | 개시 | Mizuho | Neutral |
| 2020-01-31 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2019-09-05 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2019-07-15 | 업그레이드 | Goldman | Sell → Neutral |
| 2019-05-31 | 개시 | H.C. Wainwright | Neutral |
| 2019-05-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-12-19 | 다운그레이드 | Goldman | Neutral → Sell |
| 2018-12-14 | 개시 | Wolfe Research | Underperform |
| 2018-12-13 | 다운그레이드 | Credit Suisse | Outperform → Underperform |
| 2018-11-05 | 개시 | Piper Jaffray | Neutral |
| 2018-08-07 | 개시 | Stifel | Hold |
| 2018-06-21 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2018-06-06 | 개시 | B. Riley FBR, Inc. | Buy |
| 2018-05-16 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-05-11 | 개시 | BofA/Merrill | Buy |
모두보기
Alkermes Plc 주식(ALKS)의 최신 뉴스
Is Alkermes plc (8AK) stock a fit for income portfoliosRecession Risk & Consistent Growth Stock Picks - newser.com
Alkermes stock rating reiterated at Neutral by H.C. Wainwright - Investing.com Australia
ALKS Raises Its Offer to Buy Avadel In Response to Lundbeck's Proposal - Finviz
Will Alkermes plc (8AK) stock benefit from mergersWeekly Investment Recap & Community Supported Trade Ideas - newser.com
Is Alkermes plc (8AK) stock good for wealth creation2025 Investor Takeaways & Safe Entry Momentum Tips - newser.com
Is Alkermes plc (8AK) stock among top earnings playsEarnings Risk Summary & Free Weekly Watchlist of Top Performers - newser.com
What momentum indicators show for Alkermes plc stockWeekly Trade Review & Accurate Intraday Trade Tips - newser.com
Will Alkermes plc (8AK) stock benefit from infrastructure billMarket Movers & Growth Focused Stock Pick Reports - newser.com
Applying Elliott Wave Theory to Alkermes plcWeekly Risk Report & Daily Chart Pattern Signals - newser.com
What recovery options are there for Alkermes plcMarket Trend Report & Reliable Entry Point Alerts - newser.com
Alkermes Fires Back In Bidding War With Lundbeck Over Avadel - Citeline News & Insights
Alkermes, Avadel Bump Deal To $2.37B After Alternate Bid - Law360
Avadel Pharmaceuticals agrees to sweetened $2.37B takeover bid from Alkermes amid bidding war - The Business Journals
Alkermes increases offer for Avadel to $21 in cash plus CVR - Investing.com Nigeria
What data driven models say about Alkermes plc’s futureChart Signals & Proven Capital Preservation Tips - newser.com
Risk vs reward if holding onto Alkermes plcQuarterly Portfolio Review & Reliable Volume Spike Trade Alerts - newser.com
ALKS: NT2 study data support flexible orexin dosing, robust safety, and strategic market expansion - TradingView
Alkermes prevails over Lundbeck in Avadel bidding war - Pharmaceutical Technology
Insmed Stock Rise on EU Nod for Lung Disease Drug, Brinsupri - Finviz
Avadel board backs Alkermes' higher offer over Lundbeck proposal - Reuters
Avadel Pharmaceuticals Agrees to Alkermes’ Revised Acquisition Offer - PharmExec.com
Alkermes Faces Bidding Battle For Avadel Pharmaceuticals - Finimize
Alkermes Faces Pressure to Secure the Buyout of Avadel After Lundbeck's Unsolicited Bid, RBC Says - MarketScreener
Alkermes escalates bidding war; US biotech risks ‘falling behind’ China - BioPharma Dive
Alkermes Ups Bid for Avadel to $2.37 Billion After Rival Offer - Contract Pharma
H Lundbeck A/S says noted that our offer for acquiring Avadel no longer is considered superior by their board, we are currently considering our options - MarketScreener
Alkermes (ALKS) Increases Buyout Offer for Avadel Pharmaceuticals (AVDL) - GuruFocus
Alkermes raises offer for Avadel acquisition and secures $1.5 billion loan facility - Investing.com Australia
How high can Alkermes plc stock goWeekly Stock Report & Weekly Setup with High ROI Potential - newser.com
Alkermes raises Avadel buyout offer after Lundbeck’s unsolicited bid - MSN
Why Alkermes plc stock is a must watch in 2025July 2025 Analyst Calls & Real-Time Stock Price Movement Reports - newser.com
Race For Avadel Heats Up: Alkermes Raises Offer To Secure $2.37B Deal After Lundbeck Challenge - MSN
Alkermes lifts Avadel buyout offer after Lundbeck bid (ALKS) - Seeking Alpha
Alkermes Raises Offer to Acquire Avadel Pharmaceuticals - MarketScreener
Alkermes raises offer for Avadel acquisition and secures $1.5 billion loan facility By Investing.com - Investing.com South Africa
Alkermes Increases Offer for Avadel Acquisition - TipRanks
Avadel Pharmaceuticals Amends Agreement with Alkermes - TipRanks
Alkermes (ALKS) Ups Acquisition Offer for Avadel Pharmaceuticals - GuruFocus
Alkermes Plc (ALKS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
6.17%
0.67%
자본화:
|
볼륨(24시간):